Bill Rhodes

Bill Rhodes currently serves as Chairman of the Board at GEN inCode Predictive Genetics, guiding the development of products that combine genetic and clinical data to assess cardiovascular disease risk. Additionally, Bill Rhodes is a member of the Board of Directors at Inso Biosciences and EndoSound, and has held leadership roles at Nodexus Inc., OncoDNA, and OpGen, Inc. as Chairman or board member, focusing on innovative technologies in the life sciences sector. Bill Rhodes operates as Managing Partner at Third Day Advisors LLC, providing advisory services, while also mentoring entrepreneurs as a Senior Executive in Residence at Cornell University and serving in a Clinical Instructor role at Weill Cornell Medicine. Bill Rhodes holds a BS in Entomology from Cornell University and an MS in International Business from Seton Hall University.